| Report ID | Date of report | Patient age | Patient gender |
| 123087 | May, 22, 2006 | 70 | Male |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Mylotarg | gemtuzumab ozogamicin |
Cytarabine | cytarabine |
| Name |
Alanine Aminotransferase Increased |
Aspartate Aminotransferase Increased |
Blood Alkaline Phosphatase Increased |
Infusion Related Reaction |
Pyrexia |
Weight Increased |
Results from eHealthMe : 634 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Alanine Aminotransferase Increased | 83 (13.09%) |
Aspartate Aminotransferase Increased | 125 (19.72%) |
Blood Alkaline Phosphatase Increased | 53 (8.36%) |
Infusion Related Reaction | 29 (4.57%) |
Pyrexia | 102 (16.09%) |
Weight Increased | 71 (11.20%) |
Top 3 (total: 406. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Novantrone | 150 (3.12%) |
Lasix | 117 (2.43%) |
Idarubicin Hcl | 92 (1.91%) |
Death reported: 2 (0.32% of total reports)
| Name | Count (% of total reports) |
Febrile Neutropenia | 134 (21.14%) |
Sepsis | 130 (20.50%) |
Aspartate Aminotransferase Increased | 125 (19.72%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports: